jueves, 15 de agosto de 2024

FDA approves axatilimab-csfr for chronic graft-versus-host disease

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-axatilimab-csfr-chronic-graft-versus-host-disease

No hay comentarios: